CBFA2T2


Summary: In acute myeloid leukemia, especially in the M2 subtype, the t(8;21)(q22;q22) translocation is one of the most frequent karyotypic abnormalities. The translocation produces a chimeric gene made up of the 5'-region of the RUNX1 (AML1) gene fused to the 3'-region of the CBFA2T1 (MTG8) gene. The chimeric protein is thought to associate with the nuclear corepressor/histone deacetylase complex to block hematopoietic differentiation. The protein encoded by this gene binds to the AML1-MTG8 complex and may be important in promoting leukemogenesis. Several transcript variants are thought to exist for this gene, but the full-length natures of only three have been described. [provided by RefSeq, Jul 2008].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

GO terms in CBFA2T2


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
BP IEA GO:0000122 negative regulation of transcription by RNA polymerase II
BP IEA GO:0006351 transcription, DNA-templated
BP IDA GO:0010976 positive regulation of neuron projection development
BP ISS GO:0010977 negative regulation of neuron projection development
BP IEA GO:0045746 negative regulation of Notch signaling pathway
BP IBA GO:0045892 negative regulation of transcription, DNA-templated
Showing 1 to 6 of 16 rows rows per page

Gene expression in normal tissue: CBFA2T2

Gene-model tissue-cancer distribution: Bubble Plot

undefinetissue: undefine cancer: undefined model num: 0undefinedtissue: undefined cancer: PANCAN model num: 3

Gene-drug pathway distribution

ERK MAPK signaling2Protein stability and degradation1

Pathways in CBFA2T2


Loading, please wait...
Database
Pathway ID
Pathway Des.
No matching records found

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD399 Selumetinib 1
iGMDRD353 PD0325901 1
iGMDRD309 17AAG 1
Showing 1 to 3 of 3 rows

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in CBFA2T2

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​